Journal Title:Therapeutic Advances In Reproductive Health
Therapeutic Advances in Reproductive Health is a professional journal with significant influence in the field of reproductive health. Committed to publishing the latest research results, clinical practice experience, and cutting-edge perspectives on reproductive health treatment. It covers a wide range of topics, including but not limited to reproductive endocrinology, infertility treatment, assisted reproductive technologies, prenatal diagnosis, and the relationship between gynecological tumors and reproductive health.
Its characteristic lies in emphasizing innovation and practicality. The articles published in the journal not only showcase the latest breakthroughs in basic research, but also focus on exploring the application and translation of these research results in clinical practice. For example, research on novel drugs in regulating female reproductive endocrine not only elaborates on the mechanism of action of the drugs, but also shares their actual effects and potential risks in clinical treatment. It provides valuable learning resources for clinical doctors, researchers, scholars, and students in related fields, helping them to timely understand the latest treatment progress and research trends, thereby contributing to improving reproductive health services and patient treatment outcomes.
《生殖健康治療進(jìn)展》是一本在生殖健康領(lǐng)域具有顯著影響力的專業(yè)期刊。致力于發(fā)有關(guān)生殖健康治療方面的最新研究成果、臨床實(shí)踐經(jīng)驗(yàn)和前沿觀點(diǎn)。它涵蓋了廣泛的主題,包括但不限于生殖內(nèi)分泌學(xué)、不孕不育治療、輔助生殖技術(shù)、產(chǎn)前診斷、婦科腫瘤與生殖健康的關(guān)系等。
其特色在于強(qiáng)調(diào)創(chuàng)新性和實(shí)用性。期刊所發(fā)表的文章不僅展示了基礎(chǔ)研究的最新突破,還著重探討這些研究成果在臨床實(shí)踐中的應(yīng)用和轉(zhuǎn)化。例如,對(duì)于新型藥物在調(diào)節(jié)女性生殖內(nèi)分泌方面的研究,不僅詳細(xì)闡述了藥物的作用機(jī)制,還分享了其在臨床治療中的實(shí)際效果和潛在風(fēng)險(xiǎn)。它為臨床醫(yī)生、科研人員、學(xué)者以及相關(guān)專業(yè)的學(xué)生提供了寶貴的學(xué)習(xí)資源,幫助他們及時(shí)了解最新的治療進(jìn)展和研究動(dòng)態(tài),從而為改善生殖健康服務(wù)和患者的治療效果做出貢獻(xiàn)。
Therapeutic Advances In Reproductive Health由SAGE Publishing出版商出版,收稿方向涵蓋OBSTETRICS & GYNECOLOGY全領(lǐng)域,平均審稿速度 7 Weeks ,影響因子指數(shù)3.1,該期刊近期沒有被列入國(guó)際期刊預(yù)警名單,廣大學(xué)者值得一試。
按JIF指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:OBSTETRICS & GYNECOLOGY | ESCI | Q1 | 27 / 136 |
80.5% |
按JCI指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:OBSTETRICS & GYNECOLOGY | ESCI | Q3 | 74 / 136 |
45.96% |
名詞解釋:
WOS即Web of Science,是全球獲取學(xué)術(shù)信息的重要數(shù)據(jù)庫,Web of Science包括自然科學(xué)、社會(huì)科學(xué)、藝術(shù)與人文領(lǐng)域的信息,來自全世界近9,000種最負(fù)盛名的高影響力研究期刊及12,000多種學(xué)術(shù)會(huì)議多學(xué)科內(nèi)容。給期刊分區(qū)時(shí)會(huì)按照某一個(gè)學(xué)科領(lǐng)域劃分,根據(jù)這一學(xué)科所有按照影響因子數(shù)值降序排名,然后平均分成4等份,期刊影響因子值高的就會(huì)在高分區(qū)中,最后的劃分結(jié)果分別是Q1,Q2,Q3,Q4,Q1代表質(zhì)量最高。
是否OA開放訪問: | h-index: | 年文章數(shù): |
開放 | -- | 8 |
Gold OA文章占比: | 2021-2022最新影響因子(數(shù)據(jù)來源于搜索引擎): | 開源占比(OA被引用占比): |
77.27% | 3.1 | |
研究類文章占比:文章 ÷(文章 + 綜述) | 期刊收錄: | 中科院《國(guó)際期刊預(yù)警名單(試行)》名單: |
25.00% | SCIE | 否 |
歷年IF值(影響因子):
歷年引文指標(biāo)和發(fā)文量:
歷年自引數(shù)據(jù):
若用戶需要出版服務(wù),請(qǐng)聯(lián)系出版商。